FDA Inspection 1309464 — Fougera Pharmaceuticals, LLC.

Fougera Pharmaceuticals, LLC. — FEI 2410271

The FDA completed an inspection of Fougera Pharmaceuticals, LLC. on March 26, 2026 in Hicksville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 26, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hicksville, NY (United States)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance